A phase II trial of Cremorphor EL-free paclitaxel (Genexol-PM) and gemcitabine in patients with advanced non-small cell lung cancer
about
Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapyNanotechnology in respiratory medicineClinical Translation of Nanomedicine.Sensory neuron subpopulation-specific dysregulation of intracellular calcium in a rat model of chemotherapy-induced peripheral neuropathy.Polymeric Micelles as Carriers for Nerve-Highlighting Fluorescent Probe Delivery.Toward targeted therapy in chemotherapy-resistant pancreatic cancer with a smart triptolide nanomedicine.Nanotechnology applications in thoracic surgery.Enhancement of the bioavailability of a novel anticancer compound (acetyltanshinone IIA) by encapsulation within mPEG-PLGA nanoparticles: a study of formulation optimization, toxicity, and pharmacokineticsRadiolabeling polymeric micelles for in vivo evaluation: a novel, fast, and facile method.Polymeric nanoparticles: the future of nanomedicine.Anticancer Drug Delivery: An Update on Clinically Applied Nanotherapeutics.Polymeric Micelles: Recent Advancements in the Delivery of Anticancer Drugs.Lung cancer nanomedicine: potentials and pitfalls.Recent advances in amphiphilic polymers for simultaneous delivery of hydrophobic and hydrophilic drugs.Cancer drug delivery in the nano era: An overview and perspectives (Review)Facile Generation of Tumor-pH-Labile Linkage-Bridged Block Copolymers for Chemotherapeutic Delivery.Micellization of antineoplastic agent to significantly upregulate efficacy and security.Trends on polymer- and lipid-based nanostructures for parenteral drug delivery to tumors.Cancer nanomedicine: progress, challenges and opportunities.Cholesterol-Enhanced Polylactide-Based Stereocomplex Micelle for Effective Delivery of Doxorubicin.Combination therapy with micellarized cyclopamine and temozolomide attenuate glioblastoma growth through Gli1 down-regulation.Taxane-Induced Peripheral Neurotoxicity.Evolution and Clinical Translation of Drug Delivery Nanomaterials.Liver-targeting self-assembled hyaluronic acid-glycyrrhetinic acid micelles enhance hepato-protective effect of silybin after oral administration.Progress in Nanomedicine: Approved and Investigational Nanodrugs.Tethered polymer nanoassemblies for sustained carfilzomib release and prolonged suppression of proteasome activity.Pre-existing anti-polyethylene glycol antibody reduces the therapeutic efficacy and pharmacokinetics of PEGylated liposomes.Paclitaxel-loaded hollow-poly(4-vinylpyridine) nanoparticles enhance drug chemotherapeutic efficacy in lung and breast cancer cell lines
P2860
Q26745710-446A2D00-31DB-4A10-B50A-218798B82028Q28395660-206682C2-3076-42BB-970D-13AC8DF691E0Q30355939-AB57E982-B191-4910-AC1F-72B70568D119Q35798221-7A919AB2-E3E6-438C-B6E0-5AEB919AB9E8Q36361164-CB45B280-9117-417A-B743-800D6B9DCCABQ36946804-380188C0-C491-448D-90E7-5167739B8483Q37021105-CFC0D214-C688-4A5A-90BB-AEBF9A4AE01EQ37707038-0D59C9D0-73D7-47F2-B901-5FE93E061E8DQ38327170-8B9F503A-8961-4C3A-A4DF-3ABB91ABD734Q38575282-FCF1F3E0-A753-4859-B666-D8F1CE9F1685Q38577297-2BDA3C01-8FE7-4832-8CB0-7862A023AA40Q38588547-7605F52E-0A4C-4A29-8D8A-1285AE200BCDQ38608622-F0C6ABE4-8DDD-457D-AD23-FDD788240492Q38664669-000A0965-882A-4E69-A80A-F84381928C07Q38669454-B78B7071-3198-4763-A648-4A83BECDCD7AQ38804608-D27F8D4E-42EC-4EC6-ADE6-DE21108DC999Q38941828-3667D4EF-D063-4C13-BF64-F24D2EC4F72BQ38981743-BC027828-B3AF-4478-9E63-FC3A6C028AACQ39005226-B7A92B33-BFB8-4F09-9BC6-A111EB6A6C47Q42228640-171ED0D0-7378-4841-B995-A67C12636A9FQ42335701-22039B51-F3AB-479F-B6FC-CB77C421E8E2Q45759415-96F9886C-C49A-47AC-8EE5-E747332B7871Q47263594-A9A88172-A316-488E-8CE6-00EE1A327072Q48070717-3615BC9A-ABF7-405A-9ADF-4845A6A28498Q49188363-E5BC154C-A2B9-4561-B355-69BA941266EFQ52856824-B8A79FFD-0CBC-4424-8BF1-2E89EF9B7226Q55242101-DD8439EA-C5BC-41DD-8433-2F8300F28EF8Q57348620-C41EC113-E7F1-4CF3-A95E-66FAD2D5E8B2
P2860
A phase II trial of Cremorphor EL-free paclitaxel (Genexol-PM) and gemcitabine in patients with advanced non-small cell lung cancer
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A phase II trial of Cremorphor ...... ced non-small cell lung cancer
@ast
A phase II trial of Cremorphor ...... ced non-small cell lung cancer
@en
type
label
A phase II trial of Cremorphor ...... ced non-small cell lung cancer
@ast
A phase II trial of Cremorphor ...... ced non-small cell lung cancer
@en
prefLabel
A phase II trial of Cremorphor ...... ced non-small cell lung cancer
@ast
A phase II trial of Cremorphor ...... ced non-small cell lung cancer
@en
P2093
P2860
P1476
A phase II trial of Cremorphor ...... ced non-small cell lung cancer
@en
P2093
Dong Bok Shin
Eun Kyung Cho
Hee Kyung Ahn
Jeong-Woong Park
Shin Myung Kang
Sun Jin Sym
Sun Young Kyung
Sung Hwan Jeong
P2860
P2888
P304
P356
10.1007/S00280-014-2498-5
P50
P577
2014-06-07T00:00:00Z
P5875
P6179
1050144000